Comparison of nanoduct versus macroduct sweat test for the diagnosis of cystic fibrosis in the newborn screening programme in Switzerland

J. Barben, C.S. Rueegg, S. Gallati, C.E. Kuehni, M. Baumgartner, T. Torresani, M.H. Schoeni, the Swiss CF Screening Group (St. Gallen, , Zurich, Switzerland)

Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis
Disease area: Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Barben, C.S. Rueegg, S. Gallati, C.E. Kuehni, M. Baumgartner, T. Torresani, M.H. Schoeni, the Swiss CF Screening Group (St. Gallen, , Zurich, Switzerland). Comparison of nanoduct versus macroduct sweat test for the diagnosis of cystic fibrosis in the newborn screening programme in Switzerland. Eur Respir J 2012; 40: Suppl. 56, 3384

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The diagnosis of cystic fibrosis by sweat test: the establishment of age specific reference intervals
Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know?
Year: 2007


1-PRO "Newborn screening for cystic fibrosis should be added to routine newborn screening programmes"
Source: Annual Congress 2010 - Pro/Con debates: 1. To screen or not to screen for cystic fibrosis: is it still the question, 2. Specific immunotherapy for asthma
Year: 2010

Early diagnosis from newborn screening maximises survival in severe cystic fibrosis
Source: ERJ Open Res, 4 (2) 00109-2017; 10.1183/23120541.00109-2017
Year: 2018



Intestinal current measurement (ICM) as a new diagnostic test for cystic fibrosis (CF)
Source: Annual Congress 2011 - Cystic fibrosis: New aspects of diagnosis, inflammation and detecting exacerbation
Year: 2011

Potential difference test is valuable in the diagnosis of cystic fibrosis (CF)
Source: Eur Respir J 2004; 24: Suppl. 48, 614s
Year: 2004

Should the D1152H variant be included in cystic fibrosis newborn screening programmes?
Source: Virtual Congress 2020 – Cystic fibrosis
Year: 2020


Characteristics of cystic fibrosis patients diagnosed after false negative cystic fibrosis newborn screening results
Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis
Year: 2019

Can step be a maximal test in children with cystic fibrosis?
Source: Annual Congress 2009 - Paediatric lung function, imaging and methodology in health and disease
Year: 2009


A borderline, or negative sweat test, leads to a diagnostic delay in hypertrypsinaemic cystic fibrosis (CF) infants with mild CFTR mutations
Source: Eur Respir J 2001; 18: Suppl. 33, 124s
Year: 2001

Newborn screening in Europe
Source: Research Seminar 2006 - Preventing respiratory sequelae in children diagnosed with cystic fibrosis by newborn screening
Year: 2006


Difficulty in diagnosis of patients who have cystic fibrosis like symptoms and borderline sweat test
Source: Eur Respir J 2006; 28: Suppl. 50, 716s
Year: 2006

Diagnostic efficiency of sweat conductivity testing in cystic fibrosis
Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Year: 2015


Regular routine SF6 multiple breath washout in infants with cystic fibrosis born after implementation of neonatal screening
Source: International Congress 2019 – Physiology of cystic fibrosis
Year: 2019


Non cystic fibrosis bronchiectasis in a pediatric clinic – 5 year evaluation
Source: Eur Respir J 2006; 28: Suppl. 50, 490s
Year: 2006

Characterisation of leaks during multiple breath washout and their influence on test results
Source: International Congress 2015 – Paediatric respiratory physiology
Year: 2015

Six minute test in children and adults with cystic fibrosis
Source: Virtual Congress 2020 – Exploring exercise responses in respiratory diseases
Year: 2020


Is newborn screening for cystic fibrosis cost-effective?
Source: Annual Congress 2010 - Does cost-effectiveness go together with best quality of treatment? New drivers in medicine
Year: 2010



Diagnostic value of serological tests against Pseudomonas aeruginosa in cystic fibrosis patients
Source: Annual Congress 2010 - New aspects of cystic fibrosis
Year: 2010

Short term effects of chest physiotherapy in children with cystic fibrosis assessed by a new lung function test
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new basic and clinical physiology research
Year: 2012